Abstract:Objective To investigate the effect of LncRNA-MEG3 on the proliferation and apoptosis of gastric cancer and the chemosensitivity of cisplatin. Methods Using human normal gastric epithelial cell GES1 as control cells, the expressions of LncRNA-MEG3 in MKN28, SGC7901, AGS and BGC823 gastric cancer cells were detected by qRT-PCR; the plasmid that overexpressed MEG3 was transfected into BGC823 cells (pcDNA3.1- MEG3 group), and blank plasmid was added as negative control (pcDNA3.1 group), and blank control group was set up, and the expression of LncRNA-MEG3 was detected by qRT-PCR cells transfected with 48h; BGC823 cells were treated by pcDNA3.1-MEG3 and cisplatin alone or together, and CCK8 assay and flow cytometry were used to detect cell viability and apoptosis rate; the expression of STAT3, p-STAT3Cyclin D1 and Bcl-2 protein were detected by western blotting. Results The expression of LncRNA-MEG3 in gastric cancer cells was lower than that in GES1 cells (P < 0.05); the relative expression of LncRNA-MEG3 in four groups was significantly different (P < 0.05); the expressions of Cyclin D1, Bcl-2 and p-STAT3 protein were significantly lower in pcDNA3.1-MEG3 group and cisplatin group than those in pcDNA3.1 group, but apoptosis rate was significantly higher (P < 0.05). Conclusions The expression of LncRNA-MEG3 decreases in gastric cancer cells. Overexpression of LncRNA-MEG3 can reduce gastric cancer cell viability and induce cell apoptosis, and increase the chemosensitivity of cisplatin, which is related to downregulation of STAT3 signaling pathway.